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The immune response to Staphylococcal  nuclease  (nuclease) 1 is under the control of 
H-2- and non-H-2-1inked/r genes (1).  Antinuclease antibodies from inbred strains of 
mice have been shown  (2)  to bear characteristic  cross-reactive idiotypes  (CRI)  that 
are expressed by all individuals of the same strain.  Expression of these idiotypes (Id) 
is linked to the heavy chain allotype locus (Igh-C)  (3), although some of these Id are 
also shared by more than one mouse strain. 
Administration of exogenous anti-Id to mice has been used to study the control of 
Id expression  in  several  experimental  model  systems  (reviewed  in  4).  We  recently 
demonstrated  that  administration  of purified  heterologous anti-Id  to  mice leads  to 
the appearance of Id-bearing Ig in the serum of the treated animals in the absence of 
detectable  antigen  (nuclease)-binding  activity  (Id'). This phenomenon was observed 
after  treatment  of A/J  animals  with  pig  anti-A/J  Id  (5)  and  after  treatment  of 
BALB/c animals with pig anti-BALB/c Id (6).  In each case, treatment  with anti-Id 
was also found to result  in the appearance  of antigen-specific helper T  (Tn)  cells in 
the spleen.  These TH cells  as well  as those  from nuclease-primed  animals  (22)  were 
shown  to bear  idiotypic determinants  by abrogation  of T  cell  help  after  treatment 
with anti-Id plus complement  (C) before culture. 
In  the  previous  studies,  anti-Id  was  administered  to strains  that  were  known  to 
produce  the  corresponding  Id  after  immunization  with  nuclease.  In  the  present 
experiments, we examined the effects of administration of anti-BALB/c Id to B 10.D2 
mice,  a  strain  not  normally expressing  the  predominant  BALB/c CRI.  Our results 
indicate  that  after  administration  of anti-Id  in complete  Freund's  adjuvant  (CFA), 
these recipients  also produce Id'. Mice producing such "inappropriate"  Id' also have 
been found to possess antigen-specific primed TH cells. These T  cells, as opposed to T 
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cells from  nuclease-primed BI0.D2  mice,  bear the inappropriate BALB/c  idiotypic 
determinants  as  indicated  by their  functional  elimination by treatment  with  anti- 
BALB/c Id plus C. These results therefore indicate that it is possible to manipulate 
the proportions of Id-bearing antigen-specific TH cells by treatment with anti-Id. 
Materials  and  Methods 
Animals.  BI0.D2/SgSn  mice were obtained from  The Jackson  Laboratory, Bar  Harbor, 
Maine. BALB/c mice were either purchased from The Jackson Laboratory or were obtained 
through  the Mammalian Genetics Section, National Institutes of Health,  from  the Charles 
River Breeding Laboratories, Wilmington, Mass. Miniature swine were bred and housed at the 
National Institutes of Health Animal Facility, Poolesville, Md. 
Antigens.  Nuclease  was  purified  by  published  methods  (7,  8)  or  was  purchased  from 
Boehringer-Mannheim Biochemicals, Indianapolis, Ind. Although no major contaminants were 
found on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of 
the commercial preparation ofnuclease, the specific activity of this material was approximately 
one-half that of enzyme prepared in our laboratory. We therefore conjugated the commercial 
preparation to trinitrobenzene sulfonic acid (TNBS)  for use in  in  vitro assays, but  we used 
nuclease purified in our laboratory for all immunizations of animals in vivo. Keyhole limpet 
hemocyanin  (KLH;  lot  530195)  was  purchased  from  Calbiochem-Behring Corp.,  American 
Hoechst  Corp.,  San  Diego, Calif.  Both  proteins were conjugated with  TNBS  as previously 
described (9) at levels of 13 and 19 TNP groups per 100,000 mol wt of protein for KLH and for 
nuclease, respectively. 
Antibodies.  BALB/c antinuclease antibodies (Id) were affinity purified on nuclease coupled 
to Sepharose 4B, as previously described (2). Anti-Id sera from miniature swine were prepared 
and  affinity purified as previously described (5).  Pig anti-BALB/c Ig was derived from the 
anti-Id serum by affinity chromatography on normal BALB/c Ig during the purification of the 
anti-Id. Elution conditions were the same for anti-BALB/c Ig and anti-Id. 
Serologic Assays for  Id  and  Antinuclease Activity.  Id  was  detected  by  a  hemagglutination 
inhibition (HAI) assay using Id-coated sheep erythrocyte (SRBC) and an appropriate dilution 
of pig anti-Id (5). An enzyme-linked immunosorbent assay (ELISA) was also used to detect Id. 
For this assay, 96-well flat bottomed microtiter plates (Dynatech Laboratories, Inc., Alexandria, 
Va.)  were coated with  purified BALB/c anti-nuclease (1  #g/ml,  200  /~l/well in  phosphate- 
buffered saline [PBS]) overnight at 4°C. Unadsorbed Id was removed from the wells by washing 
three times with 0.025%  Tween 20 in PBS (PBS-Tween) before use. Serial twofold dilutions of 
test sera were preincubated with purified pig anti-BALB/c Id (anti-Id) at 2.5 ~g/ml in PBS- 
Tween for 1 h at room temperature. 200/~1 of this mixture was transferred to each well of the 
washed Id-coated ELISA plate and incubated for  1 h  at room temperature. The plates were 
then  washed  with  PBS-Tween  and  200  ktl  of a  1:500  dilution of horse  radish  peroxidase- 
conjugated rabbit anti-porcine Ig (Miles Laboratories, Inc., Elkhart, Ind.) was added to each 
well for  1 h.  The plates were washed with  PBS-Tween, and  200/~l substrate (0.1 mg/ml 0- 
phenylenediamine plus 0.075%  hydrogen peroxide) was added. The reaction was stopped after 
30 min by addition of 50/tl 8 N HCI. Absorbance was read at 492 nm in a Titertek Multiskan 
apparatus (Flow Laboratories, Inc., Rockville, Md.). Antinuclease activity was determined by 
passive hemagglutination of nuclease-coated SRBC (5). 
Immumzations.  Mice were immunized with  100 #g nuclease i.p. in 0.2 ml of a  1:1 emulsion 
with CFA (H37Ra;  Difco Laboratories, Detroit, Mich.). Anti-Id-treated mice received 20 p,g 
purified anti-Id intraperitoneally in CFA on day 0 unless otherwise indicated. All animals were 
2-6 mo old at immunization, and spleens were harvested from 3 to 12 wk thereafter. Mice were 
immunized with 100 #g KLH or TNP-KLH in 0.1 ml saline emulsified with an equal volume 
of CFA for in vitro secondary plaque-forming cell (PFC) responses. 
Preparation of Cell Populations.  Splenic T  cells were isolated by nylon wool filtration (10). T 
cell-depleted spleen cells (B plus accessory cells) were prepared by treatment of spleen cells with 
rabbit anti-mouse brain serum and guinea pig C or monoclonal anti-Tby-1.2 and rabbit C  (9, 
11). 
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and for augmented in vitro responses to TNP-nuclease have been described in detail elsewhere 
(9,  12). Briefly, the in vitro response to TNP-nuclease required the presence of nuclease-primed 
T  cells; unprimed spleen cells or T  cells did not generate significant responses.  IgM anti-TNP 
antibody  forming cells (PFC)  were generated by nuclease-primed spleen cells or coculture of 
nuclease-primed T  cells and  unprimed  B  plus accessory cells with TNP-nuclease.  No IgG- or 
IgA-secreting anti-TNP  PFC were detected  (12).  Cells were cultured  in 200-gl flat bottomed 
Falcon microtiter plates (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) at 
a final cell density of 1.5 ×  l0  s cells/ml and a final antigen concentration of 10 p.g/ml for TNP- 
nuclease and 5/.tg/ml for TNP-KLH. Cultures were harvested on day 4 or day 5.  Direct anti- 
TNP PFC were detected on TNP-coated SRBC as previously described (I2, 13). Conditions for 
the in vitro secondary IgG responses to TNP-KLH and TNP-nuclease are described in detail 
elsewhere (6). Briefly, 3 X  10  s TNP-primed B cells (TNP-KLH-primed spleen cells treated with 
anti-Thy-l.2 plus C) were cocuhured with graded numbers of unprimed  or primed  (nuclease, 
anti-Id, or KLH)  T  cells, and  responses  to TNP-nuclease  and  TNP-KLH were assessed.  For 
these secondary responses, antigen concentrations were 0.001 #g/ml for TNP-KLH and 0.1 gg/ 
ml for TNP-nuclease.  IgG-secreting anti-TNP  PFC were measured  using a  facilitating rabbit 
anti-mouse Ig (N. L. Cappel Laboratories, Cochranville, Pa.). 
Results are expressed  as the geometric mean of PFC from  triplicate cultures calculated  as 
PFC/10  s cultured cells. The geometric SE is given in parentheses after the geometric mean. 
Anti-Id Plus C Treatment of Cells.  T  cells at a  final concentration of 2.5  ×  10  ° cells/ml were 
incubated with purified pig anti-BALB/c Id or purified normal pig Ig or pig anti-BALB/c Ig 
at a  final concentration of 250 #g/ml in minimum essential medium containing  10% FCS for 
30 rain at 37°C. These cells were then washed three times before incubation with a  1:7 dilution 
of screened rabbit  C  for 30 min at 37°C. The cells were then washed three times, resuspended 
in culture medium, and recounted before addition to in vitro cultures. Cell yields after treatment 
of nuclease-primed T  cells with these reagents ranged from 50 to 90%. No significant difference 
was noted in the yields after treatment  with C  alone, pig anti-BALB/c Ig plus C, or pig anti- 
BALB/c Id plus C. 
Results 
Id Production  in BALB/c and BIO.D2 Mice in Response  to Nuclease or Anti-Id.  As shown 
in  Table  I,  four  independently  derived  pools of ascites  from  B 10.D2  mice hyperim- 
TABLE  I 
Id in Serum and Ascites of Nuclease and Pig Anti-BALB/c Id-primed BALB/c and 
BIO.D2 Mice 
Strain  Priming 
Antinuclease  BALB/c Id* 
(log2 HA  (log2 HAI 
titer on  titer on Id-  nucIease- 
SRBC)  SRBC) 
BALB/c:[:  Nuclease  10  7 
B 10.D2 1016:~  Nuclease  11  < 1 
B10.D2  1027:[:  Nuclease  11  <1 
B10.D2 26l:~  Nuclease  10  <1 
B10.D2  1439~  Nuclease  7  <1 
BALB/c§  Pig aBALB/c Id-CFA[[  < 1  7 
B10.D2§  Pig aBALB/c Id-CFAII  <1  4 
* Pig anti-BALB/c Id was used at a dilution of 1:4,000. 
Ascites pooled from 10 to 20 hyperimmunized mice. 
§ Serum  pooled  from  five  animals  and  absorbed  on  normal  pig  Ig  coupled  to 
Sepharose. 
H  One dose  12.5/xg purified pig anti-BALB/c Id in 0.2 ml emulsion  injected intraper- 
itoneally with CFA, day 0. MILLER  ET  AL,  193 
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Fie.  1.  ELISA assay of B 10,D2 antinuclease antibodies for BALB/c cross-reactive Id. The ordinate 
shows the  absorbance  at  492  nm.  Absorbance  of uninhibited  control  was  0.75.  Absorbance  of 
peroxidase-eonjugated rabbit anti-porcine Ig to purified BALB/c Id on the plate was 0.1. Normal 
BALB/c serum, 0;  BALB/c antinuclease aseites, O;  B10.D2 antinuclease ascites, V;  uninhibited 
anti-ld control, D. 
munized with nuclease were tested for expression of the BALB/c Id by HA1. Despite 
antinuclease titers approximately equivalent to those of BALB/c antinuclease sera, 
none of these ascites demonstrated significant expression of the BALB/c Id. B 10.D2 
antinuclease ascites were also tested for expression of the BALB/c Id by an ELISA 
inhibition assay in which partial cross-reactivity might be seen more readily (Fig.  1). 
In this assay, B 10.D2 antinuclease showed inhibition slightly greater than the normal 
BALB/c serum control; however, complete inhibition as seen with BALB/c antinu- 
clease was never reached, suggesting the absence of the majority of BALB/c Id in the 
B10.D2  response.  In  addition,  as  will  be shown  below  (Fig.  4 A),  antigen-specific 
helper  T  cells  from  nuclease-primed  B10.D2,  as  opposed  to  those  from  nuclease- 
primed  BALB/c,  were  not  eliminated  by  anti-BALB/c  Id  plus  C.  These  results 
suggested that the normal B 10.D2 humoral and cellular responses to nuclease do not 
include the BALB/c Id in substantial amounts. We therefore chose B10.D2 mice to 
examine  the  effects of anti-BALB/c Id  administration  in  a  high  responder strain 
similar  to  BALB/c at  the H-2  locus but  not  normally expressing the  BALB/c Id. 
BALB/c and B10.D2 mice were immunized with pig anti-BALB/c Id in CFA. Both 
strains produced Id-bearing Ig that  did not bind nuelease (Id')  (Table I); however, 
the titer of the BALB/c Id' induced in the B 10.D2 mice was lower than in similarly 
treated  BALB/c  animals.  We  have  designated  the  appearance  of BALB/c  Id'  in 
B 10.D2 as expression of inappropriate Id'. 
Anti-BALB/c  Id  Treatment of BIO.D2  Animals  Leads to  Generation of Antigen-specific 
Helper T Cells. Previous studies showed that treatment of BALB/c mice with nuclease 
(12, 22) or pig anti-BALB/c Id (6) led to appearance of nuclease-specific Tn cells in 
the  spleens  of these  animals  and  a  consequent  ability  of these  whole  spleen  cell 
populations to respond to TNP-nuclease in vitro. We therefore examined spleen cells 400 
MODIFICATION OF T  CELL IDIOTYPE 
from BALB/c and BI0.D2  mice primed with either nuclease or anti-BALB/c  Id. As 
shown in Table II, unprimed spleen cells  did not produce a  significant  response to 
TNP-nuclease,  although  they  were  functional  as  shown  by  the  in  vitro  primary 
response  to TNP-KLH.  However, both nuclease-primed  and  anti-Id-primed  spleen 
cells  from  BALB/c  and  B10.D2  mice  were  able  to  generate  significant  anti-TNP- 
nuclease responses. 
We  have  shown  previously  (12)  that  the  in  vitro  responses  of whole  spleen  cell 
populations  to  TNP-nuclease  are  dependent  on  the  presence  of  primed  Tn  cells 
specific for nuclease. The antigenic specificity of Tn cells from BALB/c mice primed 
TABLE 1I 
Anti-BALB/c Id Treatment of Both BALB/c and BIO.D2 Mice Primes  for Responses to 
TNP-Nuclease 
Source of  Treatment  spleen cells 
In vitro antigen challenge 
No Ag  TNP-Nase*  TNP-KLH:I: 
PFC/106 cultured  cells 
BALB/c  None  8 (1.26){}  5 (1.26)  162 (l:ll) 
BALB/c  Nuclease  5 (1.44)  89 (1.24)  151  (1.03) 
BALB/ct[  Anti-Id  i0 (1.22)  147 (l.54)  175 (1,23) 
B10.D2  None  5 (1.44)  12 (1.10)  96 (1.19) 
B10.D2  Nuclease  5 (1.26)  103 (1.14)  114 (1.04) 
B10.D2[[  Anti-ld  8 (1.53)  189 (l.64)  198 (1.47) 
* TNP-Nase was added to cultures at 5 btg/ml final concentration. 
TNP-KLH was added to cultures at  I0 ~g/ml final concentration. 
§ Figures are geometric mean with geometric SE in parentheses. 
[[ Animals were primed with 20 ~g pig anti-BALB/c Id in CFA. 
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rio.  2.  Helper T cells from anti-Id-primed and nuclease-primed BI0.D2 are specific for nuclease 
is secondary IgG responses. Each culture contained 3 X  l0  s anti-Thy-l.2 plus C-treated TNP-KLI-t- 
primed (B plus accessory cells)  (B 10.D2).  Graded numbers of T  cells were added as indicated on the 
abscissa. In (A), cultures were challenged with TNP-nuclease; in (B), cultures were challenged with 
TNP-KLH. 0,  indicates nuclease-primed BI0.D2  T  cells; O, anti-BALB/c Id-primed T  cells; II, 
KLH-primed BI0.D2 T  cells. MILLER ET AL. 
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FIo. 3.  Id of nuclease-primed (A, B) and anti-Id-primed  (C, D) BALB/c T cells. T cells from 
nuclease-primed (closed symbols) or anti-ld-primed (open symbols) BALB/c mice were added to 3 
X 10  5 unprimed BALB/c B plus accessory cells and challenged in vitro with TNP-nuclease (A, C) 
or  TNP-KLH  (B,  D).  Before culture,  T  cells were untreated  (0,  ©)  or  treated  with  pi~ 
anti-BALB/c Ig plus C (A, A) or with pig anti-BALB/c Id plus C (m, I-1). X indicates PFC/10  ° 
cultured cells with no added T cells. 
with anti-BALB/c Id has previously been demonstrated (6) using an in vitro secondary 
IgG PFC  response.  Because  treatment  of B10.D2  mice with  anti-BALB/c Id might 
produce unexpected  activation  of T  cells  other than  those specific  for nuclease,  we 
examined the antigenic specificity of the anti-Id-primed B 10.D2 T  cells using the IgG 
secondary PFC response.  As seen in Fig.  2, anti-Id and nuclease priming of B10.D2 
mice generated Tn cells for TNP-nclease IgG responses (Fig. 2 A) but not TNP-KLH 
secondary responses  (Fig.  2 B).  These  results  suggested  that  anti-BALB/c  Id could 
prime antigen-specific  helper T  cells in a  strain  in which that  Id does not comprise 
the dominant humoral or cellular response to nuclease. 
Nuclease-specific Helper T Cells  from BIO.D2 Mice Primed with Pig Anti-BALB/c Id Bear 
BALB/c Id.  We found previously (6,  12)  that nuclease-primed  T  cells from BALB/c 
and B 10.D2 mice cooperate equally well with either unprimed BALB/c or unprimed 
B10.D2 B cells for the anti-hapten  response. Because these strains are both H-2 ~ and 
Mls b,  allogeneic  effects  were  not  observed  (22).  We  therefore  examined  the  Id 
expressed on nuclease and anti-Id-primed BALB/c and B 10.D2 T  cells by coculturing 
a  single  population  of unprimed  BALB/c  (B  plus  accessory)  cells  with  the  various 
primed  T  cells.  In  this  manner,  potential  differences  between  B  cell  populations 196  MODIFICATION  OF  T  CELL  IDIOTYPE 
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FxG. 4.  Id of nuclease-primed  (A,  B)  and anti-Id-primed  (C,  D)  BI0.D2  T  cells.  T  cells  from 
nuclease-primed (closed  symbols)  or anti-Id-primed (open  symbols) B10.D2 mice were added to 3 
×  10  5 unprimed BALB/c B plus accessory  cells and challenged in vitro with TNP-nuclease (A, C) 
or TNP-KLH  (B, D). Before culture,  T cells were either  untreated (0, O) or treated  with pig anti- 
BALB/c Ig plus C (&, A) or with pig anti-BALB/c  Id plus C (11, I-1). 
responding to the hapten TNP in each culture were avoided. As shown in Fig. 3 A, C, 
both nuclease-primed and anti-Id-primed BALB/c T cells provided help for the TNP- 
nuclease response.  Treatment  of these T  cells with pig anti-Id plus C  before culture 
significantly diminished the responses to TNP-nuclease but had no effect on responses 
to TNP-KLH  (Fig. 2 B, D). Control treatment with pig anti-BALB/c Ig derived from 
the anti-Id serum during its purification had no effect on either response, As seen in 
Figure 4 A, C, T  cells from B10.D2 mice primed either with nuclease or with anti-Id 
also  generated  help  for  anti-TNP-nuclease  responses.  However,  whereas  nuclease- 
primed B 10.D2 T cells were unaffected by treatment with pig anti-BALB/c Id and C, 
similar treatment of anti-BALB/c Id-primed B 10.D2 T  cells significantly diminished 
responses to TNP nuclease. Responses to TNP-KLH were again unaffected by anti-Id 
plus C  treatment  (Fig.  4 B, D).  Thus,  nuclease-specific  Tn  cells  from  B10.D2  mice 
primed  with  anti-BALB/c  Id  appeared  to  express  BALB/c  idiotypic  determinants 
not detected on helper T  cells from B 10.D2 mice immunized with nuclease. 
Discussion 
The  experiments  described  here  indicate  that  in  vivo  treatment  of BI0.D2  mice 
with  pig anti-BALB/c  Id  leads  to  the  appearance  of both  nuclease-specific  helper  T 
cells  and non-nuclease-binding  Ig molecules  expressing  determinants  similar to  those MILLER ET AL.  197 
detectable on BALB/c antinuclease antibodies. B10.D2 mice normally do not express 
predominant amounts of BALB/c antinuclease Id, as evidenced by the weak inhibition 
of the binding of anti-Id to Id by B10.D2 antinuclease antibodies. The majority of 
nuclease-specific B10.D2 TH cells generated normally during the response to antigen 
also fail to express BALB/c idiotypic determinants, as evidenced by the lack of effect 
of anti-Id plus C  on nuclease-primed B10.D2 T  cells.  Thus, it appears that a strain 
that does not normally express a particular Id (or does so at low levels) in response to 
antigens can nevertheless be induced to express this Id on a substantial proportion of 
TH cells and  on  Ig molecules  (Id')  by treatment  with anti-Id.  We have called this 
phenomenon inappropriate Id expression. 
A result that may be analogous to those reported here has been found by LeGuern 
et al.  (14), who demonstrated that DBA/2 mice could be induced to express MOPC 
460  Id on anti-dinitrophenyl antibodies if they were immunized with anti-MOPC 
460 before immunization with dinitrophenyl-ovalbumin. 
In contrast to these findings,  Eichmann and colleagues  (15)  were able to induce 
helper T  cells in mice with anti-Id only if the recipients expressed that Id in response 
to the antigen A.CHO;  thus, the administration of anti-A5A could prime TH cells 
from A/J  mice but  not  BALB/c mice, whereas  anti-S117 could prime TH cells of 
BALB/c mice but not those of A/J mice. One possible explanation for the discrep- 
ancies among these results may involve differences in the method used to prime with 
anti-Id.  In  previous  experiments,  we  found  that  anti-Id  was  equally  effective in 
inducing Id' when given in saline or CFA to recipients that normally expressed that 
Id  during the antinuclease response.  In  the current experiments, however, B10.D2 
mice produced inappropriate Id' only when anti-BALB/c Id was given in CFA (data 
not shown). Although we have not tested T  cells in vitro from animals primed with 
inappropriate anti-Id in saline, it seems likely that the induction of Id' may correlate 
with  the appearance of primed helper T  cells.  The experiments of LeGuern et  al. 
cited  above  (14),  which  demonstrated  production  of Id  in  an  otherwise  negative 
strain, also used a regimen that included CFA for priming with anti-Id. In contrast, 
immunization with anti-A5A has been reported with saline but not with CFA (15). It 
seems possible, therefore, that priming of T  cells and subsequently B cells by anti-Id 
in a strain that does not normally express the Id requires that the treatment be given 
in CFA. This requirement may be a reflection of the existence of very small numbers 
of T  cells  bearing  the  BALB/c  Id  in  B10.D2  mice  and  the  effect of adjuvant  in 
enhancing  the  probability  that  anti-Id  present  at  the  site  of administration  will 
interact with appropriate T  cells. 
Another possible explanation for the discrepancy involves differences in Id reper- 
toires present  in  the genome. It is clear from suppression of the CRI-positive anti- 
azobenzenearsonate (ARS) response with anti-CRI in A/J mice that genes encoding 
multiple Id for anti-ARS antibodies are present in the genome but are usually not 
expressed (16). Similarly, the expression of individual idiotopes in the anti-4-hydroxy- 
3-nitrophenyl acetyl response can be regulated by administration of monoclonal anti- 
idiotopes such that  individual idiotopes may be expressed in greater quantity than 
normal (17). 
Viewed in this context, the inhibition of anti-BALB/c Id binding seen with B 10.D2 
antinuclease and normal BALB/c serum (Fig.  1) may represent low level expression 
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and Id' in B10.D2 mice after treatment with anti-BALB/c Id might reflect pertur- 
bation of mechanisms regulating idiotopes already represented in the genome. Indeed, 
it might be suggested that such enhanced expression of idiotopes could not be induced 
by  anti-Id  unless  the  appropriate  information  encoding  such  VH  sequences  were 
present in the genome. If this is the case, the inability to induce anti-A.CHO helper 
T  cells in A/J mice with anti-S 117 might be a reflection of the true absence of a germ 
line gene(s) needed to generate the appropriate amino acid sequence. 
In either case, the ability in several systems to expand the Id repertoire expressed 
by B cells and T  cells has several important  implications for the study of antibody 
and receptor diversity. First, it indicates the existence of mechanisms for regulating 
the expression of multiple V gene products. In the response to ARS, for example, one 
level of  regulation for the predominant Id may occur at the level of cellular interactions 
involving Id-specific suppressor cells  (18).  However, the mechanisms by which  the 
expression of other Id are regulated in the absence of suppression of the CRI remain 
unknown.  Another mechanism  operating at  the cellular interaction level has  been 
proposed  by  Eichmann  et  al.  (19),  who  suggested  that  expression  of one Id  in  a 
response may be increased through additional help provided by idiotypically restricted 
helper T  cells.  In addition to regulatory mechanisms operating at the level of cellular 
interactions,  other  potential  points  of  regulation,  such  as  at  the  DNA  level  of 
transcription or RNA translation, could also exist, but these have yet to be described. 
A second implication of these studies is that genetic maps of the VH region based 
on Id expression may not  be a  true reflection of the organization of VH structural 
genes.  The expression of most  Id  has been shown  to be linked to genes coding for 
heavy chain allotypes (4, 20). Such studies have usually been performed by analysis 
of the segregation of Id expression and  allotype markers  in backcross populations. 
The simplest  interpretation of these studies has been that  Id expression reflects the 
presence of structural genes linked to genes encoding heavy chain allotype determi- 
nants. However, the finding that VH structural genes may exist but not be expressed 
indicates  that  such  mapping  studies  may detect  regulatory rather  than  structural 
genes. 
Finally, these results are consistent with regulatory effects of the Id-anti-Id inter- 
actions predicted by Jerne's network hypothesis (21).  The relationship between the 
observed effects of anti-Id administered experimentally and events occurring normally 
in  vivo  remains  to  be  elucidated.  However,  these  data  are  consistent  with  the 
hypothesis that anti-Id administration in vivo leads to perturbation of the Id-anti-Id 
network normally existing in  the immune  response to nuclease.  Such perturbation 
may afford a means of specifically manipulating this immune response. 
Summary 
Immunization  of BALB/c  mice  with  nuclease  leads  to  the  production  of anti- 
nuclease antibodies bearing a  set of cross-reactive idiotypes (Id)  distinct from those 
produced by B 10.D2 mice after similar immunization.  In both strains, such immu- 
nization with  nuclease also  leads  to the production of splenic T  helper cells  (TH), 
which provide nuclease-specific help in an  in  vitro plaque-forming cell response to 
nuclease-TNP.  Pig anti-(BALB/c antinuclease)  anti-idiotypic antibodies  (pig  anti- 
BALB/c Id)  react only with TH of nuclease-primed BALB/c and  not with  B10.D2 
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After  administration  of pig  anti-BALB/c  Id  in  complete  Freund's  adjuvant  to 
BALB/c and  B10.D2  mice,  Id-bearing nonantigen-binding  molecules  were induced 
in  both  strains.  Such  treatment  also  resulted  in  the  induction  of nuclease-specific 
splenic Tit cells in both strains. BALB/c TH cells induced by anti-Id, like the majority 
of nuclease-primed  BALB/c TH cells, bore BALB/c Id, as shown by their functional 
elimination with anti-Id plus complement. B 10.D2 TH cells induced by anti-Id, unlike 
TH cells from nuclease-primed B 10.D2 mice, also bore BALB/c idiotypic determinants 
by the same criterion.  Thus, it appears that one can manipulate the expression of Id 
on  serum  immunoglobulins  and  on  antigen-specific  TH  cells  by  administration  of 
exogenous anti-Id  reagents.  These  results  have implications  both  for network  inter- 
actions in the immune response and for the genetic basis of Igh-C linked Id expression. 
Received  for publication 31 August 1981. 
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